Value proposition

Sino Biological, Inc., currently listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), is an international reagent supplier and premium technical contract service, provider. Since 2007, we have committed to providing high-quality, independently developed, and produced recombinant proteins, antibodies, and cDNA clones for basic, translational, and clinical research. Sino Biological has amassed a global presence with its headquarters in Beijing, China, and subsidiaries in Suzhou and Taizhou, China, the United States, Europe, and Japan. Including two branches in Shanghai and Guangzhou, China, we have over 645,000 square ft of office space and laboratory facilities. Moreover, a new bioprocessing center has been established in Houston as part of our expansion plans.

We have over decades of experience in recombinant protein expression, and purification from bacterial, yeast, insect, and mammalian systems. Along with our progressive technology platforms—we offer 8,000+ proteins, 14,000+ antibodies, 45,000+ gene products, and 600+ ELISA kits. Additionally, we provide CRO services including recombinant expression and production services, antibody development and production services, and biological assay services.

Sino Biological products are supported through a network of distributors in North America, Europe, and Asia. We are ISO9001, ISO13485 and CNAS certified as all products pass rigorous QC test standards, ensuring high-quality products to accelerate scientific discovery and innovation.


Recombinant Protein , Elite Antibody , ELISA kits, Gene/cDNA, CRO Service, Biotechnology tools and solutions, ProVir Viral Antigen Collection, Premium Cytokines, Recombinant Production Services, Monoclonal Antibodies, Recombinant Antibody Production, Growth Factors, Immunotherapy Targets, Viral Antigens, and Covid-19 Reagents